Moffitt Notice of Blackbaud Data Incident. Learn More
Sarcoma Clinical Trials in Tampa, FL
Sarcoma clinical trials make it possible for patients of Moffitt Cancer Center in Tampa, Florida, to access the latest therapies before those options are made widely available in other settings. Because sarcomas are relatively uncommon, clinical trials are crucial for helping oncologists determine the best ways to treat these cancers. At the same time, these trials often make additional alternatives available to patients who have limited options due to the type or stage of their cancer.
As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt is home to a robust research program – one of the most renowned programs in the Tampa area, as well as the rest of the nation. Our past clinical trials for sarcoma have led to:
- The development of novel chemotherapy medications and immunotherapies
- Increased options for patients with late-stage sarcomas that cannot be surgically removed
- Changes to the ways in which certain chemotherapy medications and radiation-based treatments are delivered, making these treatments more effective and less likely to cause side effects
- Improved supportive care options, including medications to alleviate the side effects of treatment
Individuals from Tampa, FL, and the surrounding areas who are considering clinical trials can consult with Moffitt’s experienced oncologists to identify any potential opportunities and learn more about what to expect from the clinical trial process. For instance, participants can remain in a trial until their course of treatment is complete, or they can take another approach if their oncologists determine that a different plan that has become available might be a better fit.
To request more information about our current research initiatives or to find out if sarcoma clinical trials could benefit your treatment, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. Referrals are welcome, but never required.